Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Noriyoshi Miura
Keiichiro Mori
Hadi Mostafaei
Fahad Quhal
Reza Sari Motlagh
Mohammad Abufaraj
Benjamin Pradere
Abdulmajeed Aydh
Ekaterina Laukhtina
David D’Andrea
Takashi Saika
Shahrokh F. Shariat
机构：
[1] Comprehensive Cancer Center,Department of Urology
[2] Medical University of Vienna,Department of Urology
[3] Ehime University Graduate School of Medicine,Department of Urology
[4] The Jikei University School of Medicine,Research Center for Evidence based Medicine
[5] Tabriz University of Medical Sciences,Department of Urology
[6] King Fahad Specialist Hospital,Division of Urology, Department of Special Surgery, Jordan University Hospital
[7] The University of Jordan,Department of Urology
[8] University Hospital of Tours,Institute for Urology and Reproductive Health
[9] King Faisal Medical City,Department of Urology
[10] Sechenov University,Department of Urology
[11] Weill Cornell Medical College,Department of Urology, Second Faculty of Medicine
[12] University of Texas Southwestern,undefined
[13] Karl Landsteiner Institute of Urology and Andrology,undefined
[14] Charles University,undefined
[15] European Association of Urology Research Foundation,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Prostate cancer; Testosterone; Meta-analysis; Androgen receptor-targeted agents; Castration-resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1881 / 1891
页数：10
相关论文
共 50 条
  • [21] Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review
    Chen, Wen-Jun
    Kong, Da-Ming
    Li, Liang
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (02) : 163 - 169
  • [22] The Effect of Prostate Cancer Radiotherapy on Testosterone Level: A Systematic Review and Meta-analysis
    Mortezaee, Keywan
    Motallebzadeh, Elham
    Milajerdi, Alireza
    Farhood, Bagher
    Najafi, Masoud
    Sahebkar, Amirhossein
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (06) : 636 - 642
  • [23] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Tian, Shengri
    Lei, Zhen
    Gong, Zuo
    Sun, Zhonghai
    Xu, Dongyuan
    Piao, Minhu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [24] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Shengri Tian
    Zhen Lei
    Zuo Gong
    Zhonghai Sun
    Dongyuan Xu
    Minhu Piao
    Cancer Cell International, 20
  • [25] Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Wei, ZhenHeng
    Chen, ChuXin
    Li, BoWen
    Li, YongYue
    Gu, Hong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis
    Fahmy, Omar
    Alhakamy, Nabil A.
    Khairul-Asri, Mohd G.
    Ahmed, Osama A. A.
    Fahmy, Usama A.
    Fresta, Claudia G.
    Caruso, Giuseppe
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [27] Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
    Tarrar, Talha Azam
    Anwar, Muhammad Yasir
    Ali, Muhammad Ashar
    Saeed, Memoona
    Rehman, Sana
    Bajwa, Shammas F.
    Ayub, Tooba
    Javid, Haleema
    Ali, Rimsha
    Irshad, Alaa
    Aiman, Wajeeha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [28] Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
    Wang, Xin
    Yang, Hui
    Hu, Xiaopeng
    Wang, Wei
    Yu, Xiaojia
    Wang, Shihui
    Zhang, Xiaodong
    Liu, Lihong
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 614 - 622
  • [29] Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials
    Iannantuono, Giovanni Maria
    Chandran, Elias
    Floudas, Charalampos S.
    Choo-Wosoba, Hyoyoung
    Butera, Gisela
    Roselli, Mario
    Gulley, James L.
    Karzai, Fatima
    CANCER TREATMENT REVIEWS, 2023, 120
  • [30] Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort
    Schultink, Aurelia H. M. de Vries
    Crombag, Marie-Rose B. S.
    van Werkhoven, Erik
    Otten, Hans-Martin
    Bergman, Andre M.
    Schellens, Jan H. M.
    Huitema, Aiwin D. R.
    Beijnen, Jos H.
    CANCER MEDICINE, 2019, 8 (04): : 1406 - 1415
12345